Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib Article (Web of Science)

International Collaboration

cited authors

  • Nemunaitis, John; Bauer, Sebastian; Blay, Jean-Yves; Choucair, Khalil; Gelderblom, Hans; George, Suzanne; Schoffski, Patrick; von Mehren, Margaret; Zalcberg, John; Achour, Haroun; Ruiz-Soto, Rodrigo; Heinrich, Michael C.

publication date

  • January 1, 2020

webpage

published in

category

keywords

  • DCC-2618
  • KIT
  • PDGFRA
  • Phase III trial
  • gastrointestinal stromal tumor
  • receptor tyrosine kinase
  • ripretinib
  • sarcoma
  • targeted therapy
  • tyrosine kinase inhibitor

start page

  • 4251

end page

  • 4264

volume

  • 16

issue

  • 1